An article by Robert Guth in the Wall Street Journal last week highlighted the theory that I posed in last Thursday’s post, that our global health system is designed to be reactionary and emergency-focused: That question goes to the heart of one of the most controversial debates in global health: Is humanity better served by […]
I feel a little bad for the big pharmaceutical companies. Their big announcement today amounted to little more than a mention in the “more news” section of the NYTimes, sidelined by breathless articles about Obama signing the health reform bill. But more news is truly big news: both Pfizer and GlaxoSmithKline have signed up to give […]
Popular from Press
